Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-01-11 Sale |
2023-01-13 08:13 am |
Immunovant Inc. | IMVT | Macias William L. Chief Medical Officer |
44,568 | $16.75 | $746,317 | 263,533 (Direct) |
View |
| 2022-10-21 Sale |
2022-10-25 07:43 am |
Immunovant Inc. | IMVT | Macias William L. Chief Medical Officer |
341 | $9.67 | $3,297 | 308,101 (Direct) |
View |
| 2022-10-13 Sale |
2022-10-17 08:59 am |
Immunovant Inc. | IMVT | Butchko Julia G. Chief Dev. & Tech. Officer |
928 | $9.18 | $8,519 | 391,909 (Direct) |
View |
| 2022-10-13 Sale |
2022-10-17 08:57 am |
Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer |
2,793 | $9.18 | $25,640 | 997,953 (Direct) |
View |
| 2022-10-11 Sale |
2022-10-13 4:20 pm |
Immunovant Inc. | IMVT | Barnett Eva Renee Chief Financial Officer |
12,500 | $9.44 | $118,000 | 272,857 (Direct) |
View |
| 2022-10-06 Purchase |
2022-10-07 4:32 pm |
Immunovant Inc. | IMVT | Roivant Sciences Ltd. 10% Owner |
416,667 | $6 | $2,500,002 | 73,805,331 (Direct) |
View |
| 2022-09-30 Purchase |
2022-10-04 4:27 pm |
Immunovant Inc. | IMVT | Pande Atul Director |
15,000 | $5.6 | $84,000 | 102,985 (Indirect Direct) |
View |
| 2022-09-28 Sale |
2022-09-29 5:09 pm |
Immunovant Inc. | IMVT | Butchko Julia G. Chief Dev. & Tech. Officer |
535 | $4.67 | $2,498 | 392,837 (Direct) |
View |
| 2022-09-28 Sale |
2022-09-29 5:06 pm |
Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer |
1,605 | $4.67 | $7,495 | 1,000,746 (Direct) |
View |
| 2022-09-29 Purchase |
2022-09-29 4:21 pm |
Immunovant Inc. | IMVT | Torti Frank Director |
20,000 | $5.81 | $116,200 | 393,358 (Direct) |
View |
| 2022-08-30 Sale |
2022-09-01 07:36 am |
Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer |
1,644 | $5.83 | $9,585 | 1,002,351 (Direct) |
View |
| 2022-08-30 Sale |
2022-09-01 07:33 am |
Immunovant Inc. | IMVT | Butchko Julia G. Chief Dev. & Tech. Officer |
548 | $5.83 | $3,195 | 393,372 (Direct) |
View |
| 2022-07-27 Sale |
2022-07-29 07:38 am |
Immunovant Inc. | IMVT | Butchko Julia G. Chief Dev. & Tech. Officer |
510 | $4.27 | $2,178 | 281,104 (Direct) |
View |
| 2022-07-27 Sale |
2022-07-29 07:36 am |
Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer |
1,528 | $4.27 | $6,525 | 552,731 (Direct) |
View |
| 2022-07-22 Sale |
2022-07-26 07:35 am |
Immunovant Inc. | IMVT | Macias William L. Chief Medical Officer |
322 | $4.7 | $1,513 | 195,626 (Direct) |
View |
| 2022-06-29 Sale |
2022-07-01 07:05 am |
Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer |
1,376 | $4.02 | $5,532 | 554,259 (Direct) |
View |
| 2022-06-29 Sale |
2022-07-01 07:04 am |
Immunovant Inc. | IMVT | Butchko Julia G. Chief Dev. & Tech. Officer |
460 | $4.02 | $1,849 | 281,614 (Direct) |
View |
| 2022-05-24 Sale |
2022-05-25 4:26 pm |
Immunovant Inc. | IMVT | Butchko Julia G. Chief Dev. & Tech. Officer |
492 | $3.79 | $1,865 | 282,074 (Direct) |
View |
| 2022-05-24 Sale |
2022-05-25 4:23 pm |
Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer |
1,471 | $3.79 | $5,575 | 555,635 (Direct) |
View |
| 2022-04-27 Sale |
2022-04-29 07:08 am |
Immunovant Inc. | IMVT | Butchko Julia G. Chief Dev. & Tech. Officer |
541 | $4.72 | $2,554 | 282,566 (Direct) |
View |
| 2022-04-27 Sale |
2022-04-29 07:05 am |
Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer |
1,622 | $4.72 | $7,656 | 557,106 (Direct) |
View |
| 2022-04-19 Sale |
2022-04-20 4:34 pm |
Immunovant Inc. | IMVT | Macias William L. Chief Medical Officer |
1,392 | $4.98 | $6,932 | 195,948 (Direct) |
View |
| 2022-03-24 Sale |
2022-04-14 07:18 am |
Immunovant Inc. | IMVT | Butchko Julia G. Chief Dev. & Tech. Officer |
6,381 | $5.9 | $37,648 | 283,107 (Direct) |
View |
| 2022-03-24 Sale |
2022-04-14 07:16 am |
Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer |
19,227 | $5.9 | $113,439 | 558,728 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-08-17 Option Award |
2022-08-19 4:57 pm |
N/A 2032-08-17 |
Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer |
282,464 | $0 | 425,464 (Direct) |
View |
| 2022-08-17 Option Award |
2022-08-19 4:56 pm |
N/A 2032-08-17 |
Immunovant Inc. | IMVT | Macias William L. Chief Medical Officer |
282,464 | $0 | 478,090 (Direct) |
View |
| 2022-08-17 Option Award |
2022-08-19 4:54 pm |
N/A 2032-08-17 |
Immunovant Inc. | IMVT | Butchko Julia G. Chief Dev. & Tech. Officer |
282,464 | $0 | 563,568 (Direct) |
View |
| 2022-08-17 Option Award |
2022-08-19 4:52 pm |
N/A 2032-08-17 |
Immunovant Inc. | IMVT | Barnett Eva Renee Chief Financial Officer |
282,464 | $0 | 455,005 (Direct) |
View |
| 2022-08-17 Option Award |
2022-08-19 4:50 pm |
N/A 2032-08-17 |
Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer |
1,129,856 | $0 | 1,682,587 (Direct) |
View |
| 2022-08-17 Option Award |
2022-08-19 4:48 pm |
N/A 2032-08-17 |
Immunovant Inc. | IMVT | Fromkin Andrew J. Director |
52,727 | $0 | 120,153 (Direct) |
View |
| 2022-08-17 Option Award |
2022-08-19 4:46 pm |
N/A 2032-08-17 |
Immunovant Inc. | IMVT | Pande Atul Director |
52,727 | $0 | 114,653 (Direct) |
View |
| 2022-08-17 Option Award |
2022-08-19 4:44 pm |
N/A 2032-08-17 |
Immunovant Inc. | IMVT | MIGAUSKY GEORGE V Director |
52,727 | $0 | 141,653 (Direct) |
View |
| 2022-08-17 Option Award |
2022-08-19 4:41 pm |
N/A 2032-08-17 |
Immunovant Inc. | IMVT | Hughes Douglas J. Director |
52,727 | $0 | 132,900 (Direct) |
View |
| 2022-08-17 Option Award |
2022-08-19 4:39 pm |
N/A 2032-08-17 |
Immunovant Inc. | IMVT | Torti Frank Director |
564,928 | $0 | 712,654 (Direct) |
View |
| 2022-01-28 Option Award |
2022-01-31 5:01 pm |
N/A 2032-01-28 |
Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer |
526,000 | $0 | 526,000 (Direct) |
View |
| 2022-01-10 Option Award |
2022-01-12 5:13 pm |
N/A 2032-01-10 |
Immunovant Inc. | IMVT | Torti Frank Director |
429,611 | $0 | 702,474 (Direct) |
View |
| 2022-01-10 Option Award |
2022-01-12 5:09 pm |
N/A 2032-01-10 |
Immunovant Inc. | IMVT | Fromkin Andrew J. Director |
93,218 | $0 | 276,399 (Direct) |
View |
| 2022-01-10 Option Award |
2022-01-12 5:03 pm |
N/A 2032-01-10 |
Immunovant Inc. | IMVT | MIGAUSKY GEORGE V Director |
93,218 | $0 | 220,718 (Direct) |
View |
| 2022-01-10 Option Award |
2022-01-12 5:00 pm |
N/A 2032-01-10 |
Immunovant Inc. | IMVT | Hughes Douglas J. Director |
93,218 | $0 | 289,146 (Direct) |
View |